Secondly, and to evaluate the possible role of PARP-1 in melanoma radioresistance, we investigated the benefit of inhibiting PARP-1 in three melanoma cells (2 radioresistant: HBL and MM162, and one radiosensitive: LND1). This evidence concerns the gene PARP1 and melanoma.